J
Jay Thakkar
Researcher at University of Sydney
Publications - 33
Citations - 1594
Jay Thakkar is an academic researcher from University of Sydney. The author has contributed to research in topics: Randomized controlled trial & Medicine. The author has an hindex of 12, co-authored 30 publications receiving 1187 citations. Previous affiliations of Jay Thakkar include The George Institute for Global Health & Westmead Hospital.
Papers
More filters
Journal ArticleDOI
Effect of Lifestyle-Focused Text Messaging on Risk Factor Modification in Patients With Coronary Heart Disease: A Randomized Clinical Trial
Clara K Chow,Clara K Chow,Julie Redfern,Graham S. Hillis,Graham S. Hillis,Graham S. Hillis,Jay Thakkar,Jay Thakkar,Karla Santo,Maree L. Hackett,Stephen Jan,Nicholas Graves,Laura de Keizer,Tony Barry,Severine Bompoint,Sandrine Stepien,Robyn Whittaker,Anthony Rodgers,Aravinda Thiagalingam,Aravinda Thiagalingam +19 more
TL;DR: Among patients with coronary heart disease, the use of a lifestyle-focused text messaging service compared with usual care resulted in a modest improvement in LDL-C level and greater improvement in other cardiovascular disease risk factors.
Journal ArticleDOI
Mobile Telephone Text Messaging for Medication Adherence in Chronic Disease: A Meta-analysis
Jay Thakkar,R. Kurup,Tracey-Lea Laba,Karla Santo,Aravinda Thiagalingam,Anthony Rodgers,Mark Woodward,Julie Redfern,Clara K Chow +8 more
TL;DR: Mobile phone text messaging approximately doubles the odds of medication adherence in adults with chronic disease, and this increase translates into adherence rates improving from 50% to 67.8%, or an absolute increase of 17.8%.
Journal ArticleDOI
Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review
Clara K Chow,Clara K Chow,Clara K Chow,Jay Thakkar,Jay Thakkar,Alexander I. Bennett,Graham S. Hillis,Graham S. Hillis,Michael Burke,Tim Usherwood,Kha Vo,Kris Rogers,Emily Atkins,Ruth Webster,Michael Chou,Hakim-Moulay Dehbi,Abdul Salam,Anushka Patel,Anushka Patel,Bruce Neal,David Peiris,Henry Krum,John Chalmers,Mark Nelson,Christopher M. Reid,Mark Woodward,Sarah N. Hilmer,Simon Thom,Anthony Rodgers,Anthony Rodgers +29 more
TL;DR: The findings of this small trial in the context of previous randomised evidence suggest that the benefits of quarter-dose therapy could be additive across classes and might confer a clinically important reduction in blood pressure.
Journal ArticleDOI
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial.
Clara K Chow,Emily Atkins,Emily Atkins,Graham S Hillis,Mark Nelson,Christopher M. Reid,Christopher M. Reid,Markus P. Schlaich,Peter Hay,Kris Rogers,Kris Rogers,Laurent Billot,Michael Burke,John Chalmers,Bruce Neal,Bruce Neal,Anushka Patel,Tim Usherwood,Tim Usherwood,Ruth Webster,Ruth Webster,Anthony Rodgers,Andrew Hung,Armand Edison,Angalie E Abraham,Dan Xu,Mark Bloch,Gemma A. Figtree,Janis M. Nolde,Andrew Black,Shirley Jansen,Sinjini Biswas,Andrew E. Ajani,Revathy Carnagarin,D. Wynne,M. Altman,Jay Thakkar,Aravinda Thiagalingam,Harry Klimis +38 more
TL;DR: The QUARTET trial as discussed by the authors showed that a hypertension management strategy starting with a single pill containing ultra-low-dose quadruple combination therapy would be more effective than a strategy of starting with monotherapy.
Journal ArticleDOI
Factors Influencing Engagement, Perceived Usefulness and Behavioral Mechanisms Associated with a Text Message Support Program.
Julie Redfern,Julie Redfern,Karla Santo,Karla Santo,Genevieve Coorey,Genevieve Coorey,Jay Thakkar,Jay Thakkar,Maree L. Hackett,Maree L. Hackett,Maree L. Hackett,Aravinda Thiagalingam,Aravinda Thiagalingam,Clara K Chow,Clara K Chow,Clara K Chow +15 more
TL;DR: Context and insight is provided into the factors influencing consumer engagement with a text message program aimed at improving health-related behavior and the study suggests program components that may enhance potential success but will require integration at the development stage to optimize up-scaling.